Patient leaflet - Stalevo 75 mg / 18.75 mg / 200 mg film-coated tablets
1. What Stalevo is and what it is used for
Stalevo contains three active substances (levodopa, carbidopa and entacapone) in one film-coated tablet. Stalevo is used for the treatment of Parkinson’s disease.
Parkinson’s disease is caused by low levels of a substance called dopamine in the brain. Levodopa increases the amount of dopamine and hence reduces the symptoms of Parkinson’s disease. Carbidopa and entacapone improve the antiparkinson effects of levodopa.
2. What you need to know before you take Stalevo
Do not take Stalevo if you:
- are allergic to levodopa, carbidopa or entacapone, or any of the other ingredients of this medicine (listed in section 6)
- have narrow-angle glaucoma (an eye disorder)
- have a tumour of the adrenal gland
- are taking certain medicines for treating depression (combinations of selective MAO-A and MAO-B inhibitors, or non-selective MAOinhibitors)
- have ever had neuroleptic malignant syndrome (NMS – this is a rare reaction to medicines used to treat severe mental disorders)
- haveever had non-traumatic rhabdomyolysis (a rare muscle disorder)
- have a severe liver disease.
Warnings and precautions
Talk to your doctor or pharmacist before taking Stalevo if you have or have ever had:
- a heart attack or any other diseases of the heart including cardiac arrhythmias, or of the blood vessels
- asthma or any other disease of the lungs
- a liver problem, because your dose may need to be adjusted
- kidney or hormone-related diseases
- stomach ulcers or convulsions
- if you experience prolonged diarrhoea consult your doctor as it may be a sign of inflammation of the colon
- any form of severe mental disorder like psychosis
- chronic wide-angle glaucoma, because your dose may need to be adjusted and the pressure in your eyes may need to be monitored.
Consult your doctor if you are currently taking:
- antipsychotics (medicines used to treat psychosis)
- a medicine which may cause low blood pressure when rising from a chair or bed. You should be aware that Stalevo may make these reactions worse.
Consult your doctor if during the treatment with Stalevo you:
- notice that your muscles get very rigid or jerk violently, or if you get tremors, agitation, confusion, fever, rapid pulse, or wide fluctuations in your blood pressure. If any of this happens, contact your doctor immediately.
- feel depressed, have suicidal thoughts, or notice unusual changes in your behaviour
- find yourself suddenly falling asleep, or if you feel very drowsy. If this happens, you should not drive or use any tools or machines (see also section ‘Driving and using machines’).
- notice that uncontrolled movements begin or get worse after you started to take Stalevo. If this happens, your doctor may need to change the dose of your antiparkinson medicine
- experience diarrhoea: monitoring of your weight is recommended in order to avoid potentially excessive weight loss
- experience progressive anorexia, asthenia (weakness, exhaustion) and weight decrease within a relatively short period of time. If this happens, a general medical evaluation including liver function should be considered.
- feel the need to stop using Stalevo, see section ‘If you stop taking Stalevo’.
Tell your doctor if you or your family/carer notices you are developing addiction-like symptoms leading to craving for large doses of Stalevo and other medicines used to treat Parkinson’s disease.
Tell your doctor if you or your family/carer notices you are developing urges or cravings to behave in ways that are unusual for you or you cannot resist the impulse, drive or temptation to carry out certain activities that could harm yourself or others. These behaviours are called impulse control disorders and can include addictive gambling, excessive eating or spending, an abnormally high sex drive or a preoccupation with an increase in sexual thoughts or feelings. Your doctor may need to review your treatments.
Your doctor may take some regular laboratory tests during a long term treatment with Stalevo.
If you must undergo surgery, please tell your doctor that you are using Stalevo.
Stalevo is not recommended to be used for treatment of extrapyramidal symptoms (e.g. involuntary movements, shaking, muscle rigidity and muscle contractions) caused by other medicines.
Children and adolescents
Experience with Stalevo in patients under 18 years is limited. Therefore, the use of Stalevo in children or adolescents is not recommended.
Other medicines and Stalevo
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
Do not take Stalevo if you are taking certain medicines for treating depression (combinations of selective MAO-A and MAO-B inhibitors, or nonselective MAO inhibitors).
Stalevo may increase the effects and side effects of certain medicines. These include:
- medicines used to treat depression such as moclobemide, amitriptyline, desipramine, maprotiline, venlafaxine and paroxetine
- rimiterole and isoprenaline, used to treat respiratory diseases
- adrenaline, used for severe allergic reactions
- noradrenaline, dopamine and dobutamine, used to treat heart diseases and low blood pressure
- alpha-methyldopa, used to treat high blood pressure
- apomorphine, which is used to treat Parkinson’s disease.
The effects of Stalevo may be weakened by certain medicines. These include:
- dopamine antagonists used to treat mental disorders, nausea and vomiting
- phenytoin, used to prevent convulsions
- papaverine used to relax the muscles.
Stalevo may make it harder for you to digest iron. Therefore, do not take Stalevo and iron supplements at the same time. After taking one of them, wait at least 2 to 3 hours before taking the other.
Stalevo with food and drink
Stalevo may be taken with or without food. For some patients, Stalevo may not be well absorbed if it is taken with, or shortly after eating protein-rich food (such as meats, fish, dairy products, seeds and nuts). Consult your doctor if you think this applies to you.
Pregnancy, breast-feeding and fertility
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
You should not breast-feed during treatment with Stalevo.
Driving and using machines
Stalevo may lower your blood pressure, which may make you feel light headed or dizzy. Therefore, be particularly careful when you drive or when you use any tools or machines.
If you feel very drowsy, or if you sometimes find yourself suddenly falling asleep, wait until you feel fully awake again before driving or doing anything else that requires you to be alert. Otherwise, you may put yourself and others at risk of serious injury or death.
Stalevo contains sucrose
Stalevo contains sucrose (1.4mg/tablet). If you have been told by your doctor that you have intolerance to some sugars, contact your doctor before taking this medicine.
This medicine contains less than 1mmol (23mg) sodium per tablet, that is to say essentially ‘sodium-free’.
3. How to take Stalevo
Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.
For adults and elderly:
- Your doctor will tell you exactly how many tablets of Stalevo to take each day.
- The tablets are not intended to be split or broken into smaller pieces.
- You should take only one tablet each time.
- Depending on how you respond to treatment, your doctor may suggest a higher or lower dose.
If you are taking Stalevo
50mg/12.5mg/200mg,
75mg/18.75mg/200mg,
100mg/25mg/200mg,
125mg/31.25mg/200mg or
150mg/37.5mg/200mg tablets, do not take more than 10 tablets per day.
Talk to your doctor or pharmacist if you think the effect of Stalevo is too strong or too weak, or if you experience possible side effects.
To open the bottle for the first time: open the closure, and then press with your thumb on the seal until it breaks. See picture 1.
If you take more Stalevo than you should
If you have accidentally taken more Stalevo tablets than you should, talk to your doctor or pharmacist immediately. In case of an overdose you may feel confused or agitated, your heart rate may be slower or faster than normal or the colour of your skin, tongue, eyes or urine may change.
Package leaflet: Information for the user
Picture 1
If you forget to take Stalevo
Do not take a double dose to make up for a forgotten tablet.
If it is more than 1 hour until your next dose:
Take one tablet as soon as you remember, and the next tablet at the normal time.
If it is less than 1 hour until your next dose:
Take a tablet as soon as you remember, wait 1 hour, then take another tablet. After that carry on as normal.
Always leave at least an hour between Stalevo tablets, to avoid possible side effects.
If you stop taking Stalevo
Do not stop taking Stalevo unless your doctor tells you to. In such a case your doctor may need to adjust your other antiparkinson medicines, especially levodopa, to give sufficient control of your symptoms. If you suddenly stop taking Stalevo and other antiparkinsonian medicines it may result in unwanted side effects.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them. Many of the side effects can be relieved by adjusting the dose.
If you during the treatment with Stalevo experience the following symptoms, contact your doctor immediately:
- Your muscles get very rigid or jerk violently, you get tremors, agitation, confusion, fever, rapid pulse, or wide fluctuations in your blood pressure. These can be symptoms of neuroleptic malignant syndrome (NMS, a rare severe reaction to medicines used to treat disorders of the central nervous system) or rhabdomyolysis (a rare severe muscle disorder).
- Allergic reaction, the signs may include hives (nettle rash), itching, rash, swelling of your face, lips, tongue or throat. This may cause difficulties in breathing or swallowing.
Very common (may affect more than 1 in 10 people):
- uncontrolled movements (dyskinesias)
- feeling sick (nausea)
- harmless reddish-brown discolouration of urine
- muscle pain
- diarrhoea.
Common (may affect up to 1 in 10 people):
- light-headedness or fainting due to low blood pressure, high blood pressure
- worsening of Parkinson’s symptoms, dizziness, drowsiness
- vomiting, abdominal pain and discomfort, heartburn, dry mouth, constipation
- inability to sleep, hallucinations, confusion, abnormal dreams (including nightmares), tiredness
- mental changes – including problems with memory, anxiety and depression (possibly with thoughts of suicide)
- heart or artery disease events (e.g. chest pain), irregular heart rate or rhythm
- more frequent falling
- shortness of breath
- increased sweating, rashes
- muscle cramps, swelling of legs
- blurred vision
- anaemia
- decreased appetite, decreased weight
- headache, joint pain
- urinary tract infection.
Uncommon (may affect up to 1 in 100 people):
- heart attack
- bleeding in the gut
- changes in the blood cell count which may result in bleeding, abnormal liver function tests
- convulsions
- feeling agitated
- psychotic symptoms
- colitis (inflammation of the colon)
- discolourations other than urine (e.g. skin, nail, hair, sweat)
- swallowing difficulties
- inability to urinate.
Not known (frequency cannot be estimated from the available data):
Craving for large doses of Stalevo in excess of that required to control motor symptoms, known as dopamine dysregulation syndrome. Some patients experience severe abnormal involuntary movements (dyskinesias), mood swings or other side effects after taking large doses of Stalevo.
The following side effects have also been reported:
- hepatitis (inflammation of the liver)
- itching.
You may experience the following side effects:
Inability to resist the impulse to perform an action that could be harmful, which may include:
- strong impulse to gamble excessively despite serious personal or family consequences
- altered or increased sexual interest and behaviour of significant concern to you or to others for example, an increased sexual drive
- uncontrollable excessive shopping or spending
- binge eating (eating large amounts of food in a short time period) or compulsive eating (eating more food than normal and more than is needed to satisfy your hunger).
Tell your doctor if you experience any of these behaviours; they will discuss ways of managing or reducing the symptoms.
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects, you can help provide more information on the safety of this medicine.
5. How to store Stalevo
Keep out of the sight and reach of children.
This medicine does not require any special storage conditions.
Do not take the tablets after the expiry date which is stated on the carton and bottle labels after ‘Exp’. The expiry date refers to the last day of that month.
If the tablet becomes discoloured or shows any signs of deterioration, seek the advice of your pharmacist.
Remember if your doctor tells you to stop using this medicine, return any unused medicine to your pharmacist for safe disposal. Only keep this medicine if your doctor tells you to.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.
6. Contents of the pack and other information
What Stalevo contains
The active ingredients in the Stalevo are levodopa, carbidopa and entacapone.
Each tablet contains 75mg of levodopa, 18.75mg of carbidopa and 200mg of entacapone.
The other ingredients are
Tablet core: croscarmellose sodium, magnesium stearate, maize starch, mannitol (E421) and povidone (E1201).
Film-coating: glycerol (85 per cent) (E422), hypromellose, magnesium stearate, polysorbate 80, red iron oxide (E172), sucrose and titanium dioxide (E171).
What Stalevo looks like and contents of the pack
Stalevo is a light brownish red, oval film-coated tablets marked with ‘LCE 75’ on one side and plain on the other side.
It is available in pack size of 100 tablets.
Manufactured by: Orion Corporation Orion Pharma, Joensuunkatu 7,
FI-24100 Salo, Finland.
Procured from within the EU and repackaged by the Product Licence holder: B&S Healthcare, Unit 4, Bradfield Road, Ruislip, Middlesex,
HA4 0NU, UK.
Stalevo® 75mg/18.75mg/200mg film-coated tablets; PL 18799/4281
Leaflet date: 30.01.2026
For any information about this medicine, please contact the Product Licence Holder: B&S Healthcare, Unit 4, Bradfield Road, Ruislip, Middlesex, HA4 0NU, UK.
Tel: 0800 049 9401
Email: regulatorygroup@bnshealthcare.com
Stalevo is the registered trademark of Orion Corporation.
Blind or partially sighted?
Is this leaflet hard to see or read?
Call 0208 515 3763 to obtain the leaflet in a format suitable for you.
POM